Zacks Research Estimates AbbVie’s Q1 Earnings (NYSE:ABBV)
AbbVie Inc. (NYSE:ABBV – Free Report) – Equities researchers at Zacks Research decreased their Q1 2025 earnings per share (EPS) estimates for shares of AbbVie in a report released on Tuesday, February 18th. Zacks Research analyst S. Ganoria now anticipates that the company will post earnings per share of $2.50 for the quarter, down from […]
